摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[(2S,3R,4S,5R,6R)-3,4,5-三羟基-6-(羟基甲基)四氢吡喃-2-基] 3,4,5-三羟基苯甲酸酯 | 554-37-0

中文名称
[(2S,3R,4S,5R,6R)-3,4,5-三羟基-6-(羟基甲基)四氢吡喃-2-基] 3,4,5-三羟基苯甲酸酯
中文别名
[(2S,3R,4S,5R,6R)-3,4,5-三羟基-6-(羟基甲基)四氢吡喃-2-基]3,4,5-三羟基苯甲酸酯
英文名称
glucogallin
英文别名
monogalloyl glucose;Galloyl glucopyranoside;[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] 3,4,5-trihydroxybenzoate
[(2S,3R,4S,5R,6R)-3,4,5-三羟基-6-(羟基甲基)四氢吡喃-2-基] 3,4,5-三羟基苯甲酸酯化学式
CAS
554-37-0
化学式
C13H16O10
mdl
——
分子量
332.264
InChiKey
GDVRUDXLQBVIKP-KPCWAIEQSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -1.4
  • 重原子数:
    23
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.46
  • 拓扑面积:
    177
  • 氢给体数:
    7
  • 氢受体数:
    10

安全信息

  • 海关编码:
    2914501900

SDS

SDS:58e1f6c4e85b0f92708732d3d6011f76
查看

文献信息

  • KOSMETISCHE FORMULIERUNG ENTHALTEND FLAVONOID-DERIVATE
    申请人:MERCK PATENT GmbH
    公开号:EP1363594A1
    公开(公告)日:2003-11-26
  • USE OF EXTRACTS OF MYRTLE AND OTHER MEDITERRANEAN PLANT SPECIES, AS ANTIMYCOTIC AGENT TOWARDS YEAST AND YEAST-LIKE MICROORGANISMS
    申请人:Romani, Annalisa
    公开号:EP1945237A2
    公开(公告)日:2008-07-23
  • COMPOSITION COMPRENANT UN EXTRAIT DE MYRTE ET UN SEL DE FLUOR DESTINEE A UNE APPLICATION BUCCO-DENTAIRE
    申请人:Pierre Fabre Médicament
    公开号:EP3661482B1
    公开(公告)日:2021-09-22
  • New alpha-glucosidase inhibitors and antibacterial compounds from Myrtus communis L.
    申请人:Rahman Attaur
    公开号:US20080269510A1
    公开(公告)日:2008-10-30
    Three new acylphloroglucinols, myrtucommulone-D (Compound 1), myrtucommulone-E (Compound 2), myrtucommulone-C (Compound 3), and a known acyphloroglucinol myrtucommulone B (Compound 4) were isolated from a methanolic extract of Myrtus communis L. The structures of compounds 1, 2 and 4 were also unambiguously determined by single X-ray diffraction analysis. The compounds 1-4 were found to be more potent α-glucosidase inhibitors than the clinically used standards, acarbose and deoxynojirimycin. The compound 3 exhibited the highest activity among all the acylphloroglucinols, with an IC 50 =35.4±1.15 μM. The compounds 1 and 2 also exhibited strong antibacterial activities.
  • [DE] KOSMETISCHE FORMULIERUNG ENTHALTEND FLAVONOID-DERIVATE<br/>[EN] COSMETIC FORMULATIONS CONTAINING FLAVONOID DERIVATIVES<br/>[FR] FORMULATIONS COSMETIQUES RENFERMANT DES DERIVES DE FLAVONOIDES
    申请人:MERCK PATENT GMBH
    公开号:WO2002069926A1
    公开(公告)日:2002-09-12
    Es werden kosmetische Formulierungen, pharmatische Zubereitungen, Nahrungsmittel und Nahrungsergänzungsmittel, beschrieben, die Flavonoid-Derivate enthalten. Die Flavonoid-Derivate wirken darin z.B. als UV-Filter. Einige der FLavonoid-Derivate stellen neue Verbindungen dar.
查看更多